Cargando…

Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum

Detalles Bibliográficos
Autores principales: Zhao, Zitong, Li, Lin, Du, Peina, Ma, Liying, Zhang, Weimin, Zheng, Leilei, Lan, Bo, Zhang, Bailin, Ma, Fei, Xu, Bo, Zhan, Qimin, Song, Yongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008746/
https://www.ncbi.nlm.nih.gov/pubmed/36923525
http://dx.doi.org/10.7150/thno.82636
_version_ 1784905827731111936
author Zhao, Zitong
Li, Lin
Du, Peina
Ma, Liying
Zhang, Weimin
Zheng, Leilei
Lan, Bo
Zhang, Bailin
Ma, Fei
Xu, Bo
Zhan, Qimin
Song, Yongmei
author_facet Zhao, Zitong
Li, Lin
Du, Peina
Ma, Liying
Zhang, Weimin
Zheng, Leilei
Lan, Bo
Zhang, Bailin
Ma, Fei
Xu, Bo
Zhan, Qimin
Song, Yongmei
author_sort Zhao, Zitong
collection PubMed
description
format Online
Article
Text
id pubmed-10008746
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-100087462023-03-14 Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum Zhao, Zitong Li, Lin Du, Peina Ma, Liying Zhang, Weimin Zheng, Leilei Lan, Bo Zhang, Bailin Ma, Fei Xu, Bo Zhan, Qimin Song, Yongmei Theranostics Erratum Ivyspring International Publisher 2023-02-09 /pmc/articles/PMC10008746/ /pubmed/36923525 http://dx.doi.org/10.7150/thno.82636 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Erratum
Zhao, Zitong
Li, Lin
Du, Peina
Ma, Liying
Zhang, Weimin
Zheng, Leilei
Lan, Bo
Zhang, Bailin
Ma, Fei
Xu, Bo
Zhan, Qimin
Song, Yongmei
Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum
title Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum
title_full Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum
title_fullStr Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum
title_full_unstemmed Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum
title_short Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum
title_sort transcriptional downregulation of mir-4306 serves as a new therapeutic target for triple negative breast cancer: erratum
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008746/
https://www.ncbi.nlm.nih.gov/pubmed/36923525
http://dx.doi.org/10.7150/thno.82636
work_keys_str_mv AT zhaozitong transcriptionaldownregulationofmir4306servesasanewtherapeutictargetfortriplenegativebreastcancererratum
AT lilin transcriptionaldownregulationofmir4306servesasanewtherapeutictargetfortriplenegativebreastcancererratum
AT dupeina transcriptionaldownregulationofmir4306servesasanewtherapeutictargetfortriplenegativebreastcancererratum
AT maliying transcriptionaldownregulationofmir4306servesasanewtherapeutictargetfortriplenegativebreastcancererratum
AT zhangweimin transcriptionaldownregulationofmir4306servesasanewtherapeutictargetfortriplenegativebreastcancererratum
AT zhengleilei transcriptionaldownregulationofmir4306servesasanewtherapeutictargetfortriplenegativebreastcancererratum
AT lanbo transcriptionaldownregulationofmir4306servesasanewtherapeutictargetfortriplenegativebreastcancererratum
AT zhangbailin transcriptionaldownregulationofmir4306servesasanewtherapeutictargetfortriplenegativebreastcancererratum
AT mafei transcriptionaldownregulationofmir4306servesasanewtherapeutictargetfortriplenegativebreastcancererratum
AT xubo transcriptionaldownregulationofmir4306servesasanewtherapeutictargetfortriplenegativebreastcancererratum
AT zhanqimin transcriptionaldownregulationofmir4306servesasanewtherapeutictargetfortriplenegativebreastcancererratum
AT songyongmei transcriptionaldownregulationofmir4306servesasanewtherapeutictargetfortriplenegativebreastcancererratum